EnsoData has raised $20 million in a Series B funding round, the company announced recently.

According to a release, the round was led by Questa Capital with continuing investments from Zetta Venture Partners, Venture Investors Health Fund, Supermoon Capital and Inspire Medical Systems.

The funds will enable the tech company to accelerate the adoption of its AI-powered sleep medicine solutions.

“We need to expand patient access with simpler and more economic testing while embracing new approaches for sleep apnea therapies to improve this reality,” EnsoData CEO and President Dr. Justin Mortara, said in a statement. “EnsoData’s AI solutions are uniquely positioned to do both, and this Series B fundraise will allow us to rapidly scale our commercial team to deliver the next wave of AI-driven healthcare solutions.”